Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 10.16%23.19B | 3.24%43.99B | 1.51%21.05B | 3.01%42.61B | 3.38%20.73B | 43.42%41.37B | 73.49%20.06B | 84.89%28.84B | 84.33%11.56B | 61.75%15.6B |
| Operating income | 10.16%23.19B | 3.24%43.99B | 1.51%21.05B | 3.01%42.61B | 3.38%20.73B | 43.42%41.37B | 73.49%20.06B | 84.89%28.84B | 84.33%11.56B | 61.75%15.6B |
| Cost of sales | -13.82%-18.89B | -5.06%-35.59B | -6.53%-16.59B | -8.91%-33.88B | -6.18%-15.58B | -55.71%-31.11B | -90.50%-14.67B | -93.96%-19.98B | -95.50%-7.7B | -56.24%-10.3B |
| Operating expenses | -13.82%-18.89B | -5.06%-35.59B | -6.53%-16.59B | -8.91%-33.88B | -6.18%-15.58B | -55.71%-31.11B | -90.50%-14.67B | -93.96%-19.98B | -95.50%-7.7B | -56.24%-10.3B |
| Gross profit | -3.46%4.3B | -3.79%8.4B | -13.65%4.45B | -14.87%8.73B | -4.26%5.16B | 15.72%10.26B | 39.57%5.39B | 67.25%8.86B | 65.47%3.86B | 73.64%5.3B |
| Selling expenses | 34.39%-121.48M | -9.08%-373.2M | -18.77%-185.15M | 21.84%-342.14M | 3.48%-155.89M | -29.65%-437.72M | -54.55%-161.5M | -148.70%-337.63M | -122.60%-104.49M | -103.31%-135.76M |
| Administrative expenses | -22.94%-2.21B | -14.91%-4.44B | 1.19%-1.79B | 9.46%-3.87B | 6.37%-1.82B | -31.02%-4.27B | -58.42%-1.94B | -67.11%-3.26B | -89.35%-1.22B | -61.52%-1.95B |
| Impairment and provision | -45.94%-589.98M | 59.37%-1.65B | -27.76%-404.27M | -66.14%-4.07B | -64.37%-316.44M | -1,201.07%-2.45B | -440.59%-192.51M | -91.86%-188.28M | -1.80%-35.61M | -219.22%-98.13M |
| -Goodwill impairment | ---- | 32.93%-990M | ---- | 16.63%-1.48B | ---- | ---1.77B | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -45.94%-589.98M | 74.41%-663.72M | -27.76%-404.27M | -281.90%-2.59B | -64.37%-316.44M | -260.74%-679.18M | -440.59%-192.51M | -91.86%-188.28M | -1.80%-35.61M | -219.22%-98.13M |
| Special items of operating profit | -2,414.66%-55.05M | 15.72%739.14M | -100.58%-2.19M | 50.82%638.74M | -29.27%376.71M | -34.90%423.52M | 3.35%532.61M | 26.30%650.55M | 237.06%515.34M | 124.68%515.08M |
| Operating profit | -35.82%1.33B | 144.43%2.67B | -36.30%2.07B | -69.00%1.09B | -10.48%3.25B | -38.50%3.52B | 20.44%3.63B | 57.81%5.73B | 71.36%3.01B | 83.69%3.63B |
| Financing income | 13.60%126.28M | -20.13%217.26M | -2.66%111.16M | 90.61%272M | 88.83%114.21M | 15.81%142.7M | 13.59%60.48M | -22.24%123.21M | -25.73%53.25M | 68.11%158.45M |
| Financing cost | 40.36%-64.21M | 27.68%-169.1M | 3.66%-107.67M | -8.84%-233.82M | 20.49%-111.76M | 2.82%-214.83M | -102.14%-140.57M | -92.63%-221.06M | -236.15%-69.54M | -4,777.05%-114.76M |
| Special items of earning before tax | -44.94%-54.57M | 77.30%-11.56M | -295.17%-37.65M | -247.92%-50.92M | -20.52%19.29M | -16.89%34.43M | 314.96%24.27M | 2.13%41.42M | 2.51%5.85M | 418.09%40.56M |
| Earning before tax | -34.37%1.33B | 150.70%2.71B | -37.77%2.03B | -69.03%1.08B | -8.47%3.27B | -38.56%3.49B | 19.00%3.57B | 52.71%5.67B | 65.43%3B | 78.93%3.71B |
| Tax | 31.98%-332.08M | -47.83%-832.2M | 37.39%-488.18M | 54.02%-562.94M | 4.77%-779.69M | 7.49%-1.22B | -5.74%-818.75M | -41.83%-1.32B | -61.80%-774.3M | -160.84%-933.07M |
| After-tax profit from continuing operations | -35.13%1B | 262.78%1.87B | -37.89%1.55B | -77.15%516.71M | -9.57%2.49B | -48.01%2.26B | 23.61%2.75B | 56.36%4.35B | 66.73%2.23B | 61.88%2.78B |
| Earning after tax | -35.13%1B | 262.78%1.87B | -37.89%1.55B | -77.15%516.71M | -9.57%2.49B | -48.01%2.26B | 23.61%2.75B | 56.36%4.35B | 66.73%2.23B | 61.88%2.78B |
| Minority profit | -94.21%6.09M | -70.52%66.15M | -23.42%105.21M | -29.42%224.38M | -21.99%137.39M | 0.59%317.91M | 55.56%176.13M | 230.85%316.06M | 454.80%113.22M | 100.16%95.53M |
| Profit attributable to shareholders | -30.81%996.56M | 518.59%1.81B | -38.74%1.44B | -84.96%292.34M | -8.72%2.35B | -51.82%1.94B | 21.90%2.58B | 50.16%4.03B | 60.70%2.11B | 60.78%2.69B |
| Basic earnings per share | -30.80%0.2982 | 523.25%0.5416 | -38.18%0.4309 | -84.93%0.0869 | -8.90%0.697 | -55.08%0.5768 | 9.50%0.7651 | 31.55%1.2842 | 44.78%0.6987 | 55.62%0.9762 |
| Diluted earnings per share | -31.00%0.2973 | 523.25%0.5416 | -38.18%0.4309 | -84.93%0.0869 | -8.90%0.697 | -54.94%0.5768 | 9.60%0.7651 | 32.90%1.2801 | 44.95%0.6981 | 56.19%0.9632 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.